K Number
K992446
Device Name
DAILIES (NELFILCON A) ONE-DAY
Date Cleared
1999-08-18

(27 days)

Product Code
Regulation Number
886.5925
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
DAILIES® (nelfilcon A) ONE-DAY CONTACT LENSES are indicated for daily wear for the optical correction of refractive ametropia (myopia, hyperopia, and astigmatism) in not aphakic persons with non-diseased eyes. DAILIES® (nelfilcon A) ONE-DAY CONTACT LENSES are to be prescribed for single use Daily Disposable Wear. DAILIES® lenses are not intended to be cleaned or disinfected and should be discarded after a single use.
Device Description
The DAILIES® (nelfilcon A) ONE-DAY CONTACT LENS is a daily wear soft contact lens intended for single use daily disposable wear. The lens material is 69% water and 31% nelfilcon A polymer (polyvinyl alcohol partially acetalized with N-formylmethyl acrylamide). Lenses are supplied sterile in foil sealed blister packs containing isotonic phosphate-acetate buffered saline solution.
More Information

No
The summary describes a standard contact lens and its manufacturing process, with no mention of AI, ML, image processing, or any computational analysis of data for diagnosis or treatment.

No.
The device is used for the optical correction of refractive ametropia (myopia, hyperopia, and astigmatism), which is a corrective function rather than a therapeutic one.

No.

The device is indicated for the "optical correction of refractive ametropia" and is described as a "daily wear soft contact lens." It is used for correction, not for diagnosis.

No

The device description clearly states it is a physical contact lens made of a polymer and water, supplied in blister packs. It is a tangible medical device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the "optical correction of refractive ametropia (myopia, hyperopia, and astigmatism)". This is a physical correction of vision, not a diagnostic test performed in vitro (outside the body) on biological samples.
  • Device Description: The device is a contact lens, which is a physical object placed on the eye. It does not involve the analysis of biological specimens like blood, urine, or tissue.
  • Lack of IVD Characteristics: The description does not mention any components or processes typically associated with IVDs, such as reagents, assays, or analysis of biological markers.

IVD devices are used to diagnose diseases or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. This contact lens does not fit that definition.

N/A

Intended Use / Indications for Use

DAILIES® (nelfilcon A) ONE-DAY CONTACT LENSES are indicated for daily wear for the optical correction of refractive ametropia (myopia, hyperopia, and astigmatism) in not aphakic persons with non-diseased eyes.

DAILIES® (nelfilcon A) ONE-DAY CONTACT LENSES are to be prescribed for single use Daily Disposable Wear. DAILIES® lenses are not intended to be cleaned or disinfected and should be discarded after a single use.

Product codes

86 MVN

Device Description

The DAILIES® (nelfilcon A) ONE-DAY CONTACT LENS is a daily wear soft contact lens intended for single use daily disposable wear. The lens material is 69% water and 31% nelfilcon A polymer (polyvinyl alcohol partially acetalized with N-formylmethyl acrylamide). Lenses are supplied sterile in foil sealed blister packs containing isotonic phosphate-acetate buffered saline solution.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Eye care practitioners may prescribe the lens for single-use daily disposable wear.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Clinical Testing: Not conducted for quality assurance procedural change. Lenses remain unchanged from device described and approved in Premarket Notification 510(k) K963487 and K984273.

Non-clinical Testing: Dailies lenses will continue to be manufactured as previously described in Premarket Notification 510(k) K963487 and K984273. The lens design. production process, packaging materials, finished product specifications and sterilization method and cycle remain unchanged. The only change involves the elimination of Biological Indicators as a sterilization release criteria. Having demonstrated controlled and validated sterilization conditions, verification through monitoring of physical operating parameters for the sterilizer to meet specifications becomes the mechanism for sterility release.

  • Validation of the Steam Sterilization Process: -
    A successful sterilization cycle includes a chamber temperature of 121 to 124°C for 45 consecutive minutes, with chamber pressure of 2.6 ± 0.2 bar. The sterilization cycle is based on an overkill approach, delivering sufficient lethality to provide a minimum 12-log reduction of microorganisms and at least a 10-0 probability of microbial survival regardless of the number and heat resistance of the naturally occurring microorganisms. The typical sterility assurance level (SAL) obtained during the execution of a validation study is consistently greater than 10-32

Assessment of Bioburden Levels for Packaged Product: Results obtained from measurement of product bioburden over a 4-month period demonstrate production bioburden levels are well controlled. The average presterilization bioburden results were consistently below both 1000 vegetative CFU and 20 spore forming CFU.

Key Metrics

Not Found

Predicate Device(s)

K943487, K984273

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 886.5925 Soft (hydrophilic) contact lens.

(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.

0

| | | CIBA Vision® Corporation
11460 Johns Creek Parkway
Duluth, GA USA 30097 | | | | Page 1 of 3 | | |
|----------------------------------|-------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|-----------------------------------------------------------------------------------|------------------------------------|---------------------------------|--|--|
| AUG 18 1999 | Focus® DAILIES® (nelfilcon A) ONE-DAY Soft Contact Lens
Parametric Release | | | | | | | |
| | 510(k) Summary of Safety and Effectiveness | | | | | | | |
| | | | | 510(k) Summary | | K992446 | | |
| | | 1. Submitter Information: | | | | | | |
| | | Company: | | CIBA Vision Corporation
11460 Johns Creek Parkway
Duluth, Georgia USA 30097 | | | | |
| | | Contact Person: | | Alicia M. Plesnarski, RAC
Senior Specialist, Global Regulatory Affairs | | | | |
| | | Telephone: | | 678-415-3924 | | | | |
| | | FAX: | | 678-415-3033 | | | | |
| | | Date Prepared: | | July 21, 1999 | | | | |
| 2. Device Name: | | | | | | | | |
| | | Common Name: | | Soft Contact Lens | | | | |
| | | Trade/Proprietary Name: | | Focus® DAILIES® ONE-DAY CONTACT LENS
(nelfilcon A) | | | | |
| | | Classification Name: | | Daily Wear | | Soft (hydrophilic) Contact Lens | | |
| | | Device Classification: | | | Class II {21 CFR 886.5925 (b) (1)} | | | |
| | 3. Predicate Device(s): | | | | | | | |
| | | CIBA Vision's Focus® DAILIES® (nelfilcon A) One-Day Contact Lens
Clear lenses: K943487
VISITINT® lenses: K984273 | | | | | | |
| | | | | | | | | |
| 4. Description of Device: | | | | | | | | |
| | | The DAILIES® (nelfilcon A) ONE-DAY CONTACT LENS is a daily wear soft contact lens
intended for single use daily disposable wear. The lens material is 69% water and
31% nelfilcon A polymer (polyvinyl alcohol partially acetalized with N-formylmethyl
acrylamide). | | | | | | |
| | | Lenses are supplied sterile in foil sealed blister packs containing isotonic
phosphate-acetate buffered saline solution. | | | | | | |

1

Image /page/1/Picture/0 description: The image shows the logo for CIBA Vision, a Novartis company. The word "CIBA" is in large, bold, sans-serif font at the top. Below it, the word "Vision" is written in a similar font, with the "i" replaced by an eye symbol. Underneath, the text "A Novartis Company" is written in a smaller, sans-serif font.

CIBA Vision® Corporation 11460 Johns Creek Parkwav Duluth. GA USA 30097

Focus® DAILIES® (nelfilcon A) ONE-DAY Soft Contact Lens Parametric Release

510(k) Summary of Safety and Effectiveness

5. Indications for Use:

DAILIES® (nelfilcon A) ONE-DAY CONTACT LENSES are indicated for daily wear for the optical correction of refractive ametropia (myopia, hyperopia, and astigmatism) in not aphakic persons with non-diseased eyes.

DAILIES® (nelfilcon A) ONE-DAY CONTACT LENSES are to be prescribed for single use Daily Disposable Wear. DAILIES® lenses are not intended to be cleaned or disinfected and should be discarded after a single use.

6. Description of Safety and Substantial Equivalence

6.1 Comparison to Predicate Device:

Design, material, chemical composition, manufacturing process, packaging and the sterilization method and cycle remain unchanged from description in cleared Premarket Notification 510(k) K963487 and K984273.

6.2 Clinical Testing:

Not conducted for quality assurance procedural change. Lenses remain unchanged from device described and approved in Premarket Notification 510(k) K963487 and K984273.

6.3 Non-clinical Testing:

Dailies lenses will continue to be manufactured as previously described in Premarket Notification 510(k) K963487 and K984273. The lens design. production process, packaging materials, finished product specifications and sterilization method and cycle remain unchanged. The only change involves the elimination of Biological Indicators as a sterilization release criteria. Having demonstrated controlled and validated sterilization conditions, verification through monitoring of physical operating parameters for the sterilizer to meet specifications becomes the mechanism for sterility release.

  • Validation of the Steam Sterilization Process: -
    A successful sterilization cycle includes a chamber temperature of 121 to 124°C for 45 consecutive minutes, with chamber pressure of 2.6 ± 0.2 bar. The sterilization cycle is based on an overkill approach, delivering sufficient lethality to provide a minimum 12-log reduction of microorganisms and at least a 100 probability of microbial survival regardless of the number and heat resistance of the naturally occurring microorganisms. The typical sterility assurance level (SAL) obtained during the execution of a validation study is consistently greater than 10-32

2

| CIBA
Vision.
A Novartis Company | CIBA Vision® Corporation
11460 Johns Creek Parkway
Duluth, GA USA 30097 | Page 3 of 3 |
|-------------------------------------------------------------------------------|-------------------------------------------------------------------------------|-------------|
| Focus® DAILIES® (nelfilcon A) ONE-DAY Soft Contact Lens
Parametric Release | | |
| 510(k) Summary of Safety and Effectiveness | | |

Assessment of Bioburden Levels for Packaged Product: Results obtained from measurement of product bioburden over a 4-month period demonstrate production bioburden levels are well controlled. The average presterilization bioburden results were consistently below both 1000 vegetative CFU and 20 spore forming CFU.

6.4 Ongoing controls and monitoring

Each sterilization cycle will continue to be verified through monitoring and documented verification of autoclave equipment operating parameters. All relevant related equipment is appropriately calibrated and maintained. Revalidation of the sterilization autoclave is performed annually to verify and ensure consistent operation and sterilization effectiveness. Ongoing monitoring of product bioburden is conducted to ensure low and consistent bioburden levels in the production environment are maintained.

3

Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 1 8 1999

Ms. Alicia M. Plesnarski, Senior Specialist Global Regulatory Affairs CIBA Vision Corporation 11460 Johns Creek Parkway Duluth, Georgia 30097-1556

Re: K992446

Trade Name: Focus® DAILIES® (nelfilcon A) One Day Soft Contact Lens (Parametric Release) Regulatory Class: II Product Code: 86 MVN Dated: July 21, 1999 Received: July 22, 1999

Dear Ms. Plesnarski:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

4

Page 2 - Ms. Alicia M. Plesnarski

· This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

A. Roerl Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

K

Device Name:

510(k) Number:

CIBA Vision® Focus® DAILIES® (nelfilcon A) One-Day Contact Lens

් පිහිටා විද්‍යා පිහිටා විද්‍යා පිහිටා විද්‍යා පිහිටා විද්‍යා පිහිටා විද්‍යා පිහිටා විද්‍යා පිහිටා විද්‍යා පිහිටා පිහිටි පිහිටි ප

Indications For Use:

The Focus® DAILIES® (nelfilcon A) One-Day contact lens is indicated for daily wear for the optical correction of refractive ametropia (myopia, hyperopia, and astigmatism) in not aphakic persons with non-diseased eyes.

Eye care practitioners may prescribe the lens for single-use daily disposable wear. DAILIES (nelfilcon A) lenses are not intended to be cleaned or disinfected and should be discarded after a single use.

Concurrence of CDRH, Office of Device Evaluation (ODE)

Myra Smith

(Division Sign-Off) Division of Ophthalmic Devices 510(k) Number_K 992 446

or

Prescription Use:

Over the Counter Use

Premarket Notification 510(k): Parametric Release DAILIES (nelfilcon A) One-Day Contact Lens